Skip to playerSkip to main contentSkip to footer
Business Insider
  • 12/8/2020
Ketamine, once known for its "club enhancing" effects, is now an FDA approved anti-depressant. Over four million Americans suffer from treatment-resistant depression. The new drug is a glimmer of hope for many.

Recommended

5:14
Up next
Ketamine Treatment Could Offer New Hope to Patients with Severe Depression
Tribune Broadcasting
3:31
The Brain on Drugs: Ketamine
Zoomin English
11:43
Small Changes… Big Effects! Breakthrough Therapies Are The Name Of The Game For This Biopharma
Benzinga
5:10
Low-cost ketamine therapy inaccessible for many
ABC NEWS (Australia)
1:39
New hope for patients with treatment-resistant depression
ABC NEWS (Australia)
1:00
MDMA and psychedelic therapy: who can access the newly-available drugs on prescription?
Australian Community Media
1:57
Psychiatrists able to prescribe MDMA and psilocybin for PTSD from July
ABC NEWS (Australia)
0:49
Documentary: Ketamine for therapy: Inside a psychedelic therapy session
Brut America
1:21
Researchers Say Psychedelics Could Be the Future of Antidepressants
Amaze Lab
0:40
FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in the US
Benzinga
1:23
Our Brains Release 'Feel-Good' Hormone Twice While We Eat: Study
Buzz60
1:00
Alzheimer's: New drug dubbed 'beginning of the end' in search for treatment
National World - LocalTV
5:45
Experts call for reversal of overprescription ‘epidemic’
ABC NEWS (Australia)
2:07
Psilocybin in magic mushrooms ‘significantly reduces’ symptoms of depression, trial shows
euronews (in English)
1:33
Deep Brain Stimulation Successfully Treats Woman With Severe Depression
A Plus
2:03
TGA approves psilocybin and MDMA for use in treating depression and PTSD
ABC NEWS (Australia)
0:39
A brain pacemaker holds promise vs depression
The Manila Times
2:52
Older people prescribed drugs for pain, despite lack of evidence
ABC NEWS (Australia)
12:34
Inside the race to find the first antiaging drug
Business Insider
2:05
FMTV - That Vitamin Movie (TRAILER)
FMTV
1:15
Donald Trump's tariffs have made the market unpredictable. Here's what to do.
Insider
1:26
Former Amazon employee shares how return-to-office policy impacted caregivers
Insider
1:02
Economists worry Trump's tariff formula makes harmful assumptions about trade
Insider
1:31
The 'White Lotus' cast's surprising salaries
Business Insider
1:45
Stocks see biggest single-day drop since 2020 after Trump's tariffs
Business Insider